IRIS
metadata only
Solute Transporter OCTN1/Slc22a4 Affects Disease Severity and Response to Infliximab in Experimental Colitis: Role of Gut Microbiota and Immune Modulation
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Oral probiotic delivery-based therapeutic strategies for inflammatory bowel disease.#457495
- Recent Advances in Natural Products for Colitis: Mechanisms and Translational Perspectives.#317839
- Protease-serpin-microbiome interactions in inflammatory bowel disease: toward integrated biomarkers of gut health.#646466
- Protease-serpin-microbiome interactions in inflammatory bowel disease: toward integrated biomarkers of gut health.#645296
- <i>Lactiplantibacillus plantarum</i> as a multifunctional probiotic for inflammatory bowel disease: Mechanisms, synbiotic strategies, and delivery systems#642630
Record · ID 250635
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive